<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0202221672
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        D-CURA 2500 IU oral ampule
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CHOLECALCIFEROL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        IU
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SMB Technology SA " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SMB Technology SA 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 389]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Saudi Arabian Japanese Pharmaceutical Co. Ltd.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A11CC05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>D- CURA is a vitamin product containing cholecalciferol (equivalent to vitamin D3). Vitamin D can be found in some foods and also produced by the body when skin is exposed to sunlight. Vitamin D helps the kidneys and intestine absorb calcium and it helps build bones.</p><p>D- CURA 25,000 IU is used:</p><p>&bull;&nbsp;&nbsp;&nbsp; for the prevention of vitamin D deficiency when there is a significant risk of deficiency or an increased demand for vitamin D</p><p>&bull;&nbsp;&nbsp;&nbsp; with other medicines to treat certain bone conditions, such as thinning of the bone (osteoporosis)</p><p>&bull;&nbsp;&nbsp; to treat vitamin D deficiency that has been confirmed by laboratory tests.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take D- CURA</strong></p><p>-&nbsp;&nbsp;&nbsp; if you are allergic (hypersensitive) to cholecalciferol or any of the other ingredients of D- CURA.</p><p>-&nbsp;&nbsp;&nbsp; if you have hypercalcaemia (increased blood calcium concentration)</p><p>-&nbsp;&nbsp;&nbsp; if you have hypercalciuria (increased urinary calcium concentration).</p><p>-&nbsp;&nbsp;&nbsp; if you have pseudohypoparathyroidism (disturbed parathyroid hormone metabolism), as the vitamin D requirement may be reduced due to phases of normal vitamin D sensitivity. In this case there is a risk of prolonged overdose. Better-regulatable active substances with vitamin D activity are available for this.</p><p>-&nbsp;&nbsp;&nbsp; if you have a predisposition to calcium-containing kidney stones.</p><p>-&nbsp;&nbsp;&nbsp; If you have hypervitaminosis D</p><p>-If you have serious renal impairment</p><p><strong>Take special care with D- CURA</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; if you have disturbed excretion of calcium and phosphate via the kidneys</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; if you are currently treated with benzothiadiazine derivatives (used to stimulate urinary excretion)</p><p>-&nbsp;&nbsp;&nbsp; in immobilised patients</p><p>as they are at risk of developping hypercalcaemia (increased blood calcium concentration) and hypercalci- uria (increased urinary calcium concentration)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; if you have sarcoidosis as there is a risk of increased conversion of vitamin D to its active form. In this case, your blood and urinary calcium levels should be monitored.</p><p>In patients with impaired kidney function who are treated with D- CURA, the effect on the calcium and phosphate balance should be monitored.</p><p>If other vitamin D-containing medicines are prescribed, the dose of vitamin D contained in D- CURA must be taken into consideration. The additional supplementation of vitamin D or calcium should only be carried out under medical supervision. In such cases the blood and urinary calcium levels must be monitored.</p><p>During long-term treatment with D- CURA, the blood and urinary calcium levels should be monitored and the kidney function checked by measurement of serum creatinine. These checks are particularly important in elderly patients and in concomitant treatment with cardiac glycosides (used to stimulate heart muscle function) or diuretics (used to stimulate urinary excretion). In the case of hypercalcaemia (increased blood calcium levels) or signs of impaired kidney function, the dose must be reduced or treatment interrupted. It is recommended to reduce the dose or to interrupt treatment if the urinary calcium level exceeds 7.5 mmol/24 hours (300 mg/24 hours).</p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&bull;&nbsp;&nbsp;&nbsp; Medicines that act on the heart or kidneys, such as cardiac glycosides (e.g. digoxin) or diuretics (e.g. bendroflumethazide).</p><p>The risk of an undesirable effect may increase when taking cardiac glycosides (used to stimulate the heart muscle function) due to increased blood calcium levels during treatment with vitamin D (risk of cardiac arrhythmiasj.Your ECG as well as your blood and urinary calcium levels should be monitored.</p><p>&bull;&nbsp;&nbsp;&nbsp; medicines containing vitamin D or eating food rich in vitamin D, such as, some types of vitamin D-enriched milk</p><p>&bull;&nbsp;&nbsp;&nbsp; actinomycin (a medicine used to treat some forms of cancer) and imidazole antifungals (e.g. clotrimazole and ketoconazole, medicines used to treat fungal disease). These medicines may interfere with the way your body process vitamin D</p><p>&bull;&nbsp;&nbsp;&nbsp; the following medicines because they can interfere with the effect or the absorption of vitamin D:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; antiepileptic medicines (anticonvulsants), barbiturates</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Glucocorticoids (steroid hormones such as hydrocortisone or prednisolone). These can decrease the effect of vitamin D</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; medicines that lower the level of cholesterol in the blood (such as cholestyramine, or colestipol)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; certain medicines for weight loss that reduce the amount of fat your body absorbs (e.g. orlistat)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Certain laxatives (such as liquid paraffin).</p><p>Please take into account that this applies also to medicines that you have taken recently.</p><p><strong>D- CURA with food, drink and alcohol </strong>you should take this medicine preferably together with a large meal to help your body absorb the vitamin D. You can also mix the solution with cold or lukewarm food, to help you take this medicine. For detailed information, see section 3 &quot;How to use D- CURA&quot;.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>D- CURA should only be taken during pregnancy if clearly needed and only at doses that are absolutely necessary to eliminate the deficiency. Overdose of vitamin D must be avoided during pregnancy, as prolonged hypercalcaemia (increased blood calcium concentration) can lead to physical and mental retardation as well as congenital heart and eye diseases of the child.</p><p>The recommended daily intake for pregnant women is 400 IU, however, in women who are considered to be vitamin D deficient a higher dose may be required (up to 2000 IU/day).</p><p>Vitamin D and its metabolites pass into breast milk. Overdose in infants induced in this way has not been observed.</p><p><strong>Driving and using machines</strong></p><p>There is limited information on the possible effects of this medicine on your ability to drive.</p><p>However, it is not expected that it would affect your ability to drive or to operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take D- CURA exactly as your doctor has told you.</p><p>You should check with your doctor or pharmacist if you are not sure.</p><p>You should take D- CURA preferably together with a large meal.</p><p>This medicine has a delicate taste of olive oil. The contents of the ampoule is to be emptied directly into the mouth and swallowed orally as per the diagram below.</p><p><img alt="" width="461" height="92" src="data:image/jpeg;base64,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" /></p><p>Use in children and adolescents</p><p>&nbsp;The recommended dose for:</p><p>&bull;&nbsp;&nbsp; Prevention of vitamin D deficiency in 1-0 years:</p><p>1 ampoule of D- CURA 25,000 IU every 8 weeks</p><p>&bull;&nbsp;&nbsp; Prevention of vitamin D deficiency in 18-1 years:</p><p>1 ampoule of D- CURA 25,000 IU every 6 weeks</p><p>&bull;&nbsp;&nbsp; Treatment of vitamin D deficiency in 18-0 years:</p><p>1 ampoule of D- CURA 25,000 IU once every 2 weeks for 6 weeks (followed by maintenance therapy of 1000-400 IU/day).</p><p>In children, D- CURA can be mixed with a small amount of children&#39;s foods, yogurt, milk, cheese or other dairy products. Do not mix this medicine into a bottle of milk or container of soft food, in case your child does not consume the whole portion, and does not receive the full dose. You should make sure that the entire dose is taken. For children who are no longer breast-feeding you should give the prescribed dose with a substantial meal.</p><p>Do not store any product or food mixture that contains D- CURA for use at a later time or a next meal.</p><p>Use in pregnancy and breast-feeding</p><p>This high strength formulation is not recommended.</p><p>Use in adults</p><p>The recommended dose for:</p><p>&bull;&nbsp;&nbsp; Prevention of vitamin D deficiency:</p><p>1 ampoule of D- CURA 25,000 IU once monthly. Higher doses may be required based on the advice of your doctor.</p><p>&bull;&nbsp;&nbsp; Addition to specific therapy for osteoporosis:</p><p>1&nbsp;&nbsp;&nbsp; ampoule of D- CURA 25,000 IU once monthly.</p><p>&bull;&nbsp;&nbsp; Treatment of vitamin D deficiency:</p><p>2&nbsp;&nbsp;&nbsp; ampoules of D- CURA 25,000 IU once weekly for 8-6 weeks, followed by maintenance therapy (2000-1400 IU once daily may be required), based on the advice of your doctor.</p><p>&bull;&nbsp;&nbsp;&nbsp; The recommended dosage range for the treatment of hypoparathyroidism is 10,000 to 200,000 IU vitamin D daily. Depending on serum calcium levels the daily dose is 1 ampoule or 8 ampoules D- CURA 25.000 IU (equivalent to 200,000-25,000 IU vitamin D).</p><p>For initiating the vitamin D therapy a loading dose up to 5 mg or 200.000 I.U (= 8 ampoules D- CURA 25.000 IU) may be given.</p><p>During long-term treatment with D- CURA the serum and urinary calcium levels should be monitored regularly and the kidney function checked by measurement of serum creatinine. If necessary, the dose must be adjusted according to the serum calcium levels (cf. sections 2. BEFORE YOU TAKE D- CURA ).</p><p><em><u>Method of administration</u></em></p><p>The drops are to be taken or administered according to the dosage instructions.</p><p>Adults take D- CURA with a spoonful of liquid.</p><p><em><u>Duration of administration</u></em></p><p>The duration of use depends on the course of the disease.</p><p>Please ask your doctor about how long you should continue treatment.</p><p>The therapy of rickets and osteomalacia (softening of bones) induced by vitamin D deficiency should be continued for one year. For initiating treatment, a single dose of 200,000 IU vitamin D can be administered.</p><p>If you have the impression that the effect of D- CURA is too strong or too weak, talk to your doctor or pharmacist.</p><p><strong>If you take more D- CURA than you should </strong></p><p><strong><em><u>Symptoms of overdose</u></em></strong></p><p>Ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) have a relatively low therapeutic index. The threshold for vitamin D intoxication is between 40,000 and 100,000 IU daily for 1 to 2 months in adults with normal parathyroid function. Infants and small children may react sensitively to far lower doses. Therefore, it is warned against intake of vitamin D without medical supervision.</p><p>Overdose leads to increased blood and urinary phosphorus levels, as well as hypercalcaemic syndrome (increased blood calcium levels) and consequently calcium deposits in the tissues and above all in the kidneys (kidney stones and kidney calcification) and the vessels.</p><p>The symptoms of intoxication are little characteristic and manifest as nausea, vomiting, initially also diarrhoea, later constipation, loss of appetite, weariness, headache, muscle pain, joint pain, muscle weakness, persistent sleepiness, azotaemia (elevated blood nitrogen), increased thirst, increased urgency to urinate and, in the final stage, dehydration. Typical laboratory findings are hypercalcaemia (increased blood calcium levels), hypercalciuria (increased urinary calcium levels) and increased serum -25 hydroxycalciferol.</p><p><em><u>Therapeutic measures in the event of overdose</u></em></p><p>Overdose requires measures for treating the often persisting and, in some circumstances life-threatening, hypercalcaemia (increased blood calcium levels).</p><p>The first measure is to discontinue the vitamin D preparation; it takes several weeks to normalise hypercalcaemia (increased blood calcium levels) caused by vitamin D intoxication.</p><p>Depending on the degree of hypercalcaemia (increased blood calcium concentration), measures include a diet that is low in calcium or free of calcium, abundant liquid intake, increase of urinary excretion by means of the medicine furosemide, as well as the administration of glucocorticoids (used to treat certain allergic diseases) and calcitonin (hormone to regulate blood calcium concentration).</p><p>If kidney function is adequate, blood calcium can be reliably lowered by infusions of isotonic sodium chloride solution (6-3 litres in 24 hours) with addition of furosemide (used to increase urinary excretion) and, in some circumstances, also 15 mg/kg body weight/hour sodium edetate (medicine that binds calcium in the blood), accompanied by continuous calcium and ECG monitoring. If urinary excretion is reduced, however, haemodialysis treatment with a calcium-free dialysate is indicated.</p><p>There is no special antidote.</p><p>Please ask your doctor about the symptoms of vitamin D overdose.</p><p><strong>If you forget to take D- CURA</strong></p><p>Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking D- CURA</strong></p><p>If you interrupt treatment or stop it prematurely, your complaints may worsen or occur again.</p><p>Please ask your doctor about this.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, D- CURA can cause side effects, although not everybody gets them.</p><p>Uncommon (affects less than 1 in 100 people)</p><p>Depending on the dose and duration of treatment, severe and prolonged hypercalcaemia (increased blood calcium levels) with its acute (cardiac arrhythmias, nausea, vomiting, psychic symptoms, disturbances of consciousness) and chronic consequences (increased urgency to urinate, increased thirst, loss of appetite, weight loss, kidney stones, kidney calcification, calcification in tissues outside the skeleton) can occur.</p><p>Rare (affects less than 1 in 1000 people)</p><p>&bull;&nbsp;&nbsp; Skin rash</p><p>&bull;&nbsp;&nbsp; Itching</p><p>&bull;&nbsp;&nbsp; Hives</p><p>A fatal outcome has been reported in very rare cases (see also section 3.4 Overdose).</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children. store below &deg;25C.</p><p>Store D- CURA in the original carton to protect the contents from light.</p><p>Do not use D- CURA after the expiry date which is stated on the label. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp; The active substance is cholecalciferol</p><p>-&nbsp;&nbsp;&nbsp; The other ingredients are tocopherol acetate, polyglyceryl oleate (E475), olive oil, refined, sweet orange peel oil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Transparent PVC/PVDC/PE ampoules.
D- CURA is available in packs of 4 PVC/PVDC/PE ampoules.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SAJA Pharmaceuticals</p><p>Saudi Arabian Japanese pharmaceutical company limited Jeddah - Saudi Arabia</p><p><strong>Under License from SMB /Belgium</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Feb/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">دي-كيورا عبارة عن منتج لفيتامين يحتوي على كوليكالسيفيرول (مكافئ لفيتامين د٣).</p><p dir="RTL">يستخدم دي-كيورا 25,000 وحدة دولية كعلاج أولي لنقص فيتامين د.</p><p dir="RTL">يمكن العثور على فيتامين د في بعض الأطعمة وأيضًا يستطيع الجسم ان ينتج فيتامين د عندما يتعرض الجلد لأشعة الشمس. فيتامين د يساعد الكليتين والأمعاء على امتصاص الكالسيوم ويساعد على بناء العظام.</p><p dir="RTL">&nbsp;يستخدم دي-كيورا &ndash; 25,000وحدة دولية:</p><p dir="RTL">٠&nbsp;&nbsp; للوقاية من نقص فيتامين د بالجسم عندما يكون هناك خطر كبير من نقص أو زيادة في الطلب على فيتامين د</p><p dir="RTL">٠&nbsp;&nbsp; مع الأدوية الأخرى لعلاج أمراض العظام، مثل ترقق العظام (هشاشة العظام)</p><p dir="RTL">٠&nbsp;&nbsp; لعلاج نقص فيتامين د بالجسم والذي أكدته الاختبارات المعملية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول دي-كيورا في الحالات التالية:</p><p dir="RTL">&nbsp;-إذا كنت تعاني من حساسية &quot;مفرطة&quot; تجاه كوليكالسيفيرول أو أي من مكونات دي-كيورا الأخرى.</p><p dir="RTL">&nbsp;-إذا كنت تعاني من فرط تركيز الكالسيوم بالدم.</p><p dir="RTL">&nbsp;-إذا كنت تعاني من فرط تركيز الكالسيوم في البول.</p><p dir="RTL">&nbsp;-إذا كنت تعاني من قصور العدة الدريقية الكاذب (اضطراب استغلاب الهرمون الدريقي)، حيث ان الحاجة الى فيتامين د قد تقل نتيجة لمراحل حساسية فيتامين د الطبيعية. في هذه الحالة تكون هناك خطورة تعرض ممتد لجرعة زائدة. تتوفر لهذا العرض مواد فعالة تتمتع بنشاط مماثل لفيتامين د،</p><p dir="RTL">ويمكن تنظيم عملها بشكل أفضل.</p><p dir="RTL">-إذا كان لديك أهبة؛ لتكوين حصوات الكلى المحتوية على الكالسيوم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط فيتامين د.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من قصور بوظائف الكلى.</p><p dir="RTL">توخ حذرًا خاصًا مع دي-كيورا في الحالات التالية:</p><p dir="RTL"><strong>&nbsp;</strong>-إذا كنت تعاني من اضطرابات التخلص من الكالسيوم والفوسفات عبر الكلى.</p><p dir="RTL">-إذا كنت حاليًا تتلقى علاجًا بمشتقات البنزوثياديازين (المستخدمة لتحفيز</p><p dir="RTL">إفراز البول).</p><p dir="RTL">في المرضى غير القادرين على الحركة؛ لأنهم معرضون لخطر الإصابة بفرط الكالسيوم بالدم وفرط الكالسيوم في البول.</p><p dir="RTL">&nbsp;-إذا كنت مصابًا بمرض الساركويد حيث إن هناك خطورة لزيادة تحول فيتامين د الى شكله النشط/ الفعال. في هذه الحالة، يجب مراقبة مستويات الكالسيوم لديك في الدم والبول.</p><p dir="RTL">بالنسبة للمرضى الذين يعانون من قصور بوظائف الكلى ممن يتم علاجهم ب دي-كيورا، يجب مراقبة التأثير على توازن الكالسيوم والفوسفات.</p><p dir="RTL">إذا تم وصف أدوية أخرى تحتوي على فيتامين د، فلا بد من أخذ جرعة فيتامين د التي يحتوي عليها دي-كيورا في الاعتبار. لا يجب تناول مكملات فيتامين د أو كالسيوم إضافية إلا تحت الإشراف الطبي. في هذه الحالات يجب مراقبة مستويات الكالسيوم في الدم والبول. خلال العلاج طويل المدى د دي-كيورا، يجب مراقبة مستويات الكالسيوم في الدم والبول وفحص وظائف الكلى من خلال قياس الكرياتينين في الدم.</p><p dir="RTL">تعد هذه الفحوصات هامة بشكل خاص في المرضى كبار السن ومع العلاج المتزامن بالجليكوسيدات القلبية (المستخدمة لتحفيز وظائف عضلة القلب) أو مدرات البول (المستخدمة لتحفيز إفراز البول). في حالة فرط مستويات الكالسيوم في الدم أو وجود علامات على قصور وظائف الكلى، يجب خفض الجرعة أو إيقاف العلاج. يوصى بخفض الجرعة أو إيقاف العلاج إذا تجاوز مستوى الكالسيوم في البول ٥(٧ مللي مول/ ٢٤ ساعة (.٣٠ مجم/ ٢٤ ساعة).</p><p dir="RTL">تناول أدوية أخرى</p><p dir="RTL">برجاء إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرا أية أدوية أخرى، بما في ذلك الأدوية التي حصلت عليها بدون وصفة</p><p dir="RTL">٠&nbsp;&nbsp; الأدوية التي تعمل على القلب أو الكلى، مثل الجليكوسيدات قلبية (الديجوكسين) (التي تستخدم لتحفيز وظيفة عضلة القلب) أو مدرات البول (بتدروفلوميثازايد) قد تزيد من خطر الاصابة بالأعراض الغير مرغوب فيها بسبب زيادة مستويات الكالسيوم في الدم خلال فترة العلاج مع فيتامين د (عدم انتظام ضربات القلب) لذا، يجب مراقبة مخطط كهربية القلب (رسم القلب) وكذلك مستويات الكالسيوم لديك في الدم والبول.</p><p dir="RTL">يرجى الأخذ بعين الاعتبار أن ذلك ينطبق أيضًا على الأدوية التي تناولتها</p><p dir="RTL">موخرا.</p><p dir="RTL">٠&nbsp;&nbsp; الأدوية التي تحتوي على فيتامين د أو تناول الأغذية الغنية بفيتامين د، مثل بعض أنواع فيتامين الحليب التي تحتوي على فيتامين د.</p><p dir="RTL">٠&nbsp;&nbsp; أكتينوميسين (دواء يستخدم لعلاج بعض أنواع السرطان) ومضادات الفطريات إميدازول (مثل كلوتريمازول والكيتوكونازول، والأدوية المستخدمة لعلاج الأمراض الفطرية). قد تتداخل هذه الأدوية مع تأثير أو امتصاص الجسم لفيتامين د</p><p dir="RTL">٠&nbsp;&nbsp; الأدوية التالية لأنها يمكن أن تتداخل مع تأثير أو امتصاص لفيتامين د:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; فينيتوين<strong> </strong>(التي تستخدم لعلاج الصرع) أو الباربيتورات (التي تستخدم لعلاج الصرع واضطرابات النوم والتخدير)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; الجلوكوكورتيكويدات (المستخدمة لعلاج أمراض حساسية معينة).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; الأدوية التي تخفض مستوى الكوليسترول في الدم (مثل الكولسترامين، أو كوليستيبول)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; بعض الأدوية التي تستخدم لفقدان الوزن او التي تقلل من كمية الدهون في جسمك (على سبيل المثال أورليستات)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; بعض الملينات (مثل البارافين السائل).</p><p dir="RTL">يرجى الأخذ بعين الاعتبار أن ذلك ينطبق أيضًا على الأدوية التي تناولتها</p><p dir="RTL">موخرًا.</p><p dir="RTL">دي-كيورا مع الطعام والشراب والكحول</p><p dir="RTL">يفضل أن تأخذ هذا الدواء جنبا الى جنب مع وجبة كبيرة لمساعدة جسمك على امتصاص فيتامين د. يمكنك أيضًا مزج دي-كيورا مع الطعام البارد أو الفاتر، لمساعدتك على تناوله. للحصول على معلومات مفصلة انظر القسم ٣ &quot;كيفية استخدام دي-كيورا</p><p dir="RTL">الحمل والرضاعة الطبيعية</p><p dir="RTL">استشيري الطبيب أو الصيدلي الخاص بك قبل تناول أية أدوية.</p><p dir="RTL">لا يجب تناول دي-كيورا أثناء الحمل إلا إذا كانت هناك حاجة ملحة وفقط بالجرعات التي تعتبر ضرورية جدًا لعلاج النقص. يجب تجنب الجرعة الزائدة من فيتامين د خلال الحمل؛ لأن فرط تركيز الكالسيوم في الدم لفترة طويلة قد يؤدي الى تخلف بدني وعقلي بالإضافة الى أمراض خلقية بالقلب والعينين لدى الطفل.</p><p dir="RTL">الجرعة اليومية الموصي بها للنساء الحوامل هي 400 وحدة دولية. ولكن في النساء الذين يعانون من نقص فيتامين د قد تكون هناك حاجة الى جرعة أعلى</p><p dir="RTL">(تصل 2000 وحدة دولية / يوم)</p><p dir="RTL">يمر فيتامين د ومستقلباته الى لبن الأم. لم تتم ملاحظة حدوث جرعة زائدة في الأطفال الرضع من خلال ذلك.</p><p dir="RTL">القيادة واستخدام الآلات</p><p dir="RTL">هناك معلومات محدودة بشأن الآثارالمحتملة لهذا الدواء على قدرتك على القيادة.</p><p dir="RTL">ومع ذلك، لا يتوقع أنه سوف يؤثر على القدرة على القيادة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دي-كيورا دائمًا كما أخبرك طبيبك بالضبط. يجب مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدا من كيفية التناول.</p><p dir="RTL">&nbsp;يجب تحديد الجرعة بشكل فردي بواسطة الطبيب المعالج.</p><p dir="RTL">يجب أن تتناول دي-كيورا جنبًا إلى جنب مع وجبة كبيرة.</p><p dir="RTL">&nbsp;هذا الدواء له طعم زيت الزيتون. يجب أن تفرغ محتويات الأمبولة مباشرة في الفم وابتلاعها كما في الرسم البياني أدناه.</p><p dir="RTL"><img alt="" width="461" height="92" src="data:image/jpeg;base64,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" /></p><p dir="RTL"><u>الاستعمال في الأطفال والمراهقين</u></p><p dir="RTL">الجرعة الموصي بها ل:</p><p dir="RTL">●&nbsp;&nbsp; الوقاية من نقص فيتامين D في 0-١ سنة:</p><p dir="RTL">١ أمبولة من دي-كيورا 25,000 وحدة دولية كل ٨ أسابيع</p><p dir="RTL">●&nbsp;&nbsp; الوقاية من نقص فيتامين D في ١-١٨ سنة:</p><p dir="RTL">١ أمبولة من دي-كيورا 25,000 وحدة دولية كل ٦ أسابيع</p><p dir="RTL">●&nbsp;&nbsp; علاج نقص فيتامين D في 0-١٨ سنة:</p><p dir="RTL">١ أمبولة من دي-كيورا 25,000 وحدة دولية مرة كل ٢ أسابيع لمدة ٦ أسابيع (تليها جرعة متابعة العلاج 400-1000 وحدة دولية / يوم).</p><p dir="RTL">في الأطفال، يمكن مزج دي-كيورا مع كمية صغيرة من الأطعمة، واللبن الزبادي، الحليب، الجبن أو منتجات الألبان الأخرى. لا تخلط هذا الدواء في زجاجة من الحليب أو حاوية لينة من المواد الغذائية. يجب عليك التأكد من أن الطفل قد تناول الجرعة كاملة. وبالنسبة للأطفال الذين توقفوا عن الرضاعة الطبيعية يجب اعطاء الجرعة المقررة مع وجبة كبيرة. لا تخزن أي منتج أو المواد الغذائية التي تحتوي على خليط دي-كيورا للاستخدام في وقت لاحق أو الوجبة التالية.</p><p dir="RTL">استخدام في الحمل والرضاعة الطبيعية</p><p dir="RTL">&nbsp;لا ينصح بتناول جرعات عالية.</p><p dir="RTL">استخدام في البالغين الجرعة الموصي بها ل:</p><p dir="RTL"><strong>●&nbsp;&nbsp; </strong>الوقاية من نقص فيتامين د:</p><p dir="RTL">١ أمبولة من دي-كيورا 25,000 وحدة دولية مرة واحدة شهريًا. قد تكون</p><p dir="RTL">هناك حاجة جرعات أعلى بناء على نصيحة الطبيب.</p><p dir="RTL">●&nbsp;&nbsp; إضافة الى علاج محدد للمرض هشاشة العظام:</p><p dir="RTL">١ أمبولة من دي-كيورا 25,000 وحدة دولية مرة واحدة شهريًا.</p><p dir="RTL">●&nbsp;&nbsp; علاج نقص فيتامين د:</p><p dir="RTL">٢ أمبولة من دي-كيورا 25,000 وحدة دولية مرة واحدة أسبوعيًا لمدة ٦-٨ أسابيع، تليها جرعة متابعة العلاج (14000-2000 وحدة دولية مرة واحدة يوميًا)، استنادًا إلى مشورة الطبيب. لبدء علاج فيتامين د قد تحتاج الي جرعة تصل الى ٥ ملغ أو 000,200</p><p dir="RTL">وحدة دولية (= ٨ أمبولات دي-كيورا 25,000 وحدة دولية).</p><p dir="RTL">- الجرعة الموصي بها لعلاج حالات قصور الدريقات هو 000,10 الى 000,200 وحدة دولية من فيتامين (د) يوميًا. اعتمادًا على مستويات الكالسيوم في الدم والجرعة اليومية هي ١ أمبولة الي ٨ أمبولات دي-كيورا 25,000 وحدة دولية (يعادل 25,000-000,200 وحدة دولية فيتامين د)</p><p dir="RTL">. خلال فترة العلاج طويلة الأمد مع دي-كيورا ينبغي رصد مستويات الكالسيوم في الدم والبول بانتظام وفحص وظائف الكلى عن طريق قياس مستوي الكرياتينين في الدم. إذا لزم الأمر، يجب أن يتم ضبط الجرعة وفقًا لمستويات الكالسيوم في الدم.</p><p dir="RTL">(راجع أقسام ٢. قبل القيام بتناول دي-كيورا).</p><p dir="RTL">يجب تناول النقاط أو اعطاؤها وفقا للتعليمات الخاصة بالجرعات. يتناول البالغون دي-كيورا بملعقة ممتلئة بالسائل.</p><p dir="RTL">مدة الاستخدام</p><p dir="RTL">تعتمد مدة الاستخدام على مسار المرض. اسأل طبيبك بخصوص مدة العلاج. ينبغي مواصلة العلاج من الكساح ولين العظام (تلين العظام) الناجم عن نقص فيتامين (د) لمدة سنة واحدة.</p><p dir="RTL">إذا كان لديك انطباع بأن تأثير دي- كيورا قوي جدا أو ضعيف جدا، تحدث الى الطبيب أو الصيدلي.</p><p dir="RTL">إذا تناولت كمية من دي-كيورا أكثر مما يجب</p><p dir="RTL"><u>أعراض الجرعة الزائدة</u></p><p dir="RTL">إرجوكالسيفيرول (فيتامين د ٢) وكوليكالسيفيرول (فيتامين د ٣) لهما منسب علاجي (نسبة الجرعة العلاجية الى الجرعة السامة) منخفض نسبيًا. يتراوح حد التسمم بفيتامين دبين ....٤ و1000000 وحدة دولية يوميا لمدة تتراوح من شهر واحد الى شهرين في البالغين ممن لديهم وظائف الغدة الدريقية (المجاورة للغدة الدرقية) طبيعية. قد يتفاعل الأطفال الرضع والأطفال الصغار بشكل حساس لجرعات أقل كثيرا من ذلك؛ لذا، يحذر تناول فيتامين د دون اشراف طبي.</p><p dir="RTL">تُؤدي الجرعة الزائدة الى زيادة مستويات الفسفور في الدم والبول، وكذلك الى متلازمة فرط مستويات الكالسيوم بالدم وبالتالي ترسب الكالسيوم في الأنسجة، والأهم من ذلك، في الكلى (تكوين حصوات بالكلى وتكلس الكلى) والأوعية الدموية.</p><p dir="RTL">أعراض التسمم تكون مميزة قليلًا وتظهر على هيئة غثيان، قيء، إسهال في البداية، ثم إمساك بعد ذلك، فقدان الشهية، تعب، صداع، ألم في العضلات، ألم بالمفاصل، ضعف بالعضلات، نعاس دائم، أزوتمية (زيادة النيتروجين بالدم)، عطش زائد، إلحاح زائد للتبول، وفي المرحلة النهائية، جفاف. النتائج المعملية العادية هي فرط مستويات الكالسيوم بالدم، وفرط مستويات الكالسيوم في البول وزيادة ٢٥-هيدروكسي كالسيفيرول في الدم.</p><p dir="RTL">&nbsp;<u>التدابير العلاجية في حالة تناول جرعة زائدة </u></p><p dir="RTL">تتطلب الجرعة الزائدة تدابير لعلاج فزط الكالسيوم بالدم والذي يكون مستمرا في كثير من الأحيان وفي بعض الأحوال يكون مهددا للحياة.</p><p dir="RTL">يتمثل التدبير الأول في إيقاف تناول مستحضر فيتامين د، تستغرق إعادة فرط الكالسيوم بالدم الناتج عن التسمم بفيتامين د الى وضعه الطبيعي عدة أسابيع.</p><p dir="RTL">بحسب درجة فرط الكالسيوم بالدم، تتضمن التدابير اتباع نظام غذائي منخفض الكالسيوم أو خال منه، تناول كمية وفيرة من السوائل، زيادة إفراز البول من خلال تناول عقار فروسيميد، بالإضافة إلى تناول</p><p dir="RTL">&nbsp;الجلوكوكورتيكويدات (المستخدمة لعلاج أمراض حساسية معينة) وهرمون كالسيثونين (المنظم لتركيز الكالسيوم في الدم).</p><p dir="RTL">إذا كانت وظائف الكلى مقبولة، يكون من الممكن تقليل الكالسيوم في الدم بشكل فعال من خلال تسريب محاليل كلوريد الصوديوم مساوي التوتر (٣-٦ لترات خلال ٢٤ ساعة) مع اضافة عقار فروسيميد (المستخدم لزيادة افراز<strong> </strong>البول)وأيضًا، في بعض الأحوال، إيديتات الصوديوم(دواء يؤدي الى ارتباط الكالسيوم في الدم) بمعدل ١٥ ملج/ كلج وزن الجسم في الساعة، مصحوبًا بمراقبة مخطط كهربية القلب والكالسيوم بشكل مستمر اذا كان افراز البول منخفضًا، على الرغم من ذلك، فيوصى عندئذ بالفسيل الدموي (الديال/ غسيل الكلى) باستخدام محلول خال من الكالسيوم.</p><p dir="RTL">&nbsp;لا يوجد هناك ترياق محدد.<strong> </strong></p><p dir="RTL">يرجى الاستفسار من طبيبك عن أعراض الجرعة الزائدة من فيتامين د.</p><p dir="RTL">&nbsp;إذا نسيت تناول دي-كيورا</p><p dir="RTL">&nbsp;لا تتناول جرعة مضاعفة لتعويض جرعة نسيتها</p><p dir="RTL">&nbsp;إذا توقفت عن تناول دي-كيورا</p><p dir="RTL">إذا أوقفت العلاج أو توقفت عن تناوله قبل الموعد المحدد فقد تسوء شكواك أو تعاود الظهور.</p><p dir="RTL">يُرجى استشارة طبيبك بخصوص ذلك</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا المستحضر، فاستشر الطبيب أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يسبب عقار دي-كيورا أثارا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">من غير المألوف (يؤثر على أقل من ١ في 100 شخص)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بحسب الجرعة ومدة العلاج، من الممكن أن يحدث فرط شديد وممتد لمستويات الكالسيوم بالدم مصحوبًا بعواقبه الحادة (اضطرابات النظم القلبي، غثيان، قيء، أعراض نفسية، اضطرابات الوعي) والمزمنة (إلحاح زائد للتبول، عطش زائد، فقدان الشهية، انخفاض الوزن، تكون حصوات بالكلى، تكلس الكلى، تكلس بالأنسجة خارج الهيكل العظمي.</p><p dir="RTL">نادرة (يؤثر على أقل من ١ في 1000 شخص)</p><p dir="RTL">٠&nbsp;&nbsp; طفح الجلد</p><p dir="RTL">٠&nbsp;&nbsp; الحكة</p><p dir="RTL">٠&nbsp;&nbsp; حساسية الجلد (الشري)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدًا عن متناول ورؤية الأطفال</p><p dir="RTL">يحفظ في درجة حرارة اقل من ٢٥ درجة مئوية.</p><p dir="RTL">&nbsp;احفظ دي-كيورا داخل العبوة الأصلية لحماية المحتويات من الضوء.</p><p dir="RTL">لا تستخدم دي-كيورا بعد انتهاء تاريخ الصلاحية المدون على الملصق.</p><p dir="RTL">&nbsp;يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">يجب عدم التخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-المادة الفعالة هي كوليكالسيفيرول.</p><p dir="RTL">-المكونات الأخرى هي أسيتات توكوفيرول، بولي جليسيريل أوليات (٤٧٥E)، وزيت الزيتون المكرر وزيت قشر البرتقال الحلو.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أمبولات شفافة مصنوعة من بولي فينيل الكلوريد/ بولي فينيل ثنائي الكلوريد/بولي اثيلين (PE/PVDC/PVC).</p><p dir="RTL">يتوفر دي-كيورا في عبوات بها ٤ أمبولات مصنوعة من بولي فينيل الكلوريد/ بولي فينيل ثنائي الكلوريد/ بولي اثيلين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة</p><p dir="RTL">&nbsp;جدة &mdash; المملكة العربية السعودية</p><p dir="RTL">بترخيص من شركة إس إم بى / بلجيكا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير / ٢.١٥
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                D-CURA ® 25,000 IU oral solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml solution (1 ampoule) contains 0.625 mg cholecalciferol, equivalent to 25,000 IU vitamin D.
For a full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral solution
Clear, slightly yellow, oily liquid with an orange odour
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The prevention and treatment of vitamin D deficiency.<br />As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk<br />of vitamin D insufficiency.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Paediatric posology:<br />- Prevention of deficiency 0-1 years 25000 IU (1 ampoule) every 8 weeks<br />- Prevention of deficiency 1-18 years 25000 IU (1 ampoule) every 6 weeks<br />- Treatment of deficiency 0-18 years 25000 IU (1 ampoule) once every 2 weeks for 6 weeks<br />(followed by maintenance therapy of 400-1000 IU/day)<br />Pregnancy and breastfeeding:<br />- The high strength formulation is not recommended<br />Adults:<br />- Prevention of vitamin D deficiency 25000 IU/month (1 ampoule), higher doses may be required<br />in certain situations, see below<br />- As an adjunct to specific therapy for osteoporosis: 25000 IU/month (1 ampoule)<br />- Treatment of vitamin D deficiency (&lt;25 ng/ml) 50000 IU/week (2 ampoules) for 6-8 weeks,<br />followed by maintenance therapy (1400-2000 IU/day may be required; follow-up 25(OH)D<br />measurements should be made approximately three to four months after initiating maintenance<br />therapy to confirm that the target level has been achieved)<br />- The recommended dosage range for the treatment of hypoparathyroidism is 10,000 to 200,000<br />IU vitamin D daily. Depending on serum calcium levels the daily dose is 1 ampoule or 8<br />ampoules D- CURA 25.000 IU (equivalent to 25,000&ndash;200,000 IU vitamin D).<br />- For initiating the vitamin D therapy a loading dose up to 5 mg or 200.000 I.U (= 8 ampoules DCURA 25.000 IU) may be given.<br />Certain populations are at high risk of vitamin D deficiency, and may require higher doses and<br />monitoring of serum 25(OH)D:<br />- Institutionalised or hospitalised individuals<br />- Dark skinned individuals<br />- Individuals with limited effective sun exposure due to protective clothing or consistent use of<br />sun screens<br />- Obese individuals<br />- Patients being evaluated for osteoporosis<br />- Use of certain concomitant medications (e.g., anticonvulsant medications, glucocorticoids)<br />- Patients with malabsorption, including inflammatory bowel disease and coeliac disease<br />- Those recently treated for vitamin D deficiency, and requiring maintenance therapy.<br />Special populations<br />Renal impairment<br />D-CURA should not be used in combination with calcium in patients with severe renal<br />impairment.<br />Hepatic impairment<br />No posology adjustment is required in patients with hepatic impairment.<br />Method of administration<br />Patients should be advised to take D-CURA preferably with meal (see section 5.2<br />Pharmacokinetic properties - &ldquo;Absorption&rdquo;).<br />Administration to adults:<br />The full contents of the ampoule should be either emptied into the mouth and swallowed orally,<br />or emptied onto a spoon and taken orally. D-CURA can also be taken by mixing with a small<br />amount of cold or lukewarm food immediately prior to use.<br />Administration to children:<br />In children, D-CURA can be mixed with a small amount of children&#39;s foods, yogurt, milk, cheese<br />or other dairy products. The parents should be warned not to mix D-CURA into a bottle of milk<br />or container of soft foods in case the child does not consume the whole portion, and does not<br />receive the full dose. The parents should ensure that their child takes the entire dose. For children<br />who are not breast-feeding, the prescribed dose should be administered with a meal<br />See also section 6.6, Special precautions for handling and disposal.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance(s) or to any of the excipients.
• Hypercalcaemia and/or hypercalciuria.
• Nephrolithiasis and/or nephrocalcinosis
• Serious renal impairment
• Hypervitaminosis D
• Pseudohypoparathyroidism as the vitamin D requirement may be reduced due to phases of
normal vitamin D sensitivity, involving the risk of prolonged overdose. Better-regulatable
vitamin D derivatives are available for this.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vitamin D should be used with caution in patients with impairment of renal function and the<br />effect on calcium and phosphate levels should be monitored. The risk of soft tissue calcification<br />should be taken into account.<br />Caution is required in patients receiving treatment for cardiovascular disease (see section 4.5<br />Interaction with other medicinal products and other forms of interaction - cardiac glycosides<br />including digitalis).<br />D-CURA should be prescribed with caution in patients with sarcoidosis, due to a possible<br />increase in the metabolism of vitamin D in its active form. In these patients the serum and<br />urinary calcium levels should be monitored.<br />Allowances should be made for the total dose of vitamin D in cases associated with treatments<br />already containing vitamin D, foods enriched with vitamin D, cases using milk enriched with<br />vitamin D, and the patient&#39;s level of sun exposure.<br />There is no clear evidence for causation between vitamin D supplementation and renal stones,<br />but the risk is plausible, especially in the context of concomitant calcium supplementation. The<br />need for additional calcium supplementation should be considered for individual patients.<br />Calcium supplements should be given under close medical supervision.<br />Oral administration of high-dose vitamin D (500,000 IU by single annual bolus) was reported to<br />result in an increased risk of fractures in elderly subjects, with the greatest increase occurring<br />during the first 3 months after dosing.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of anticonvulsants (such as phenytoin) or barbiturates (and possibly other drugs<br />that induce hepatic enzymes) may reduce the effect of vitamin D3 by metabolic inactivation.<br />In cases of treatment with thiazide diuretics, which decrease urinary elimination of calcium,<br />monitoring of serum calcium concentration is recommended.<br />Concomitant use of glucocorticoids can decrease the effect of vitamin D.<br />In cases of treatment with drugs containing digitalis and other cardiac glycosides, the<br />administration of vitamin D may increases the risk of digitalis toxicity (arrhythmia). Strict<br />medical supervision is needed, together with serum calcium concentration and<br />electrocardiographic monitoring if necessary.<br />Simultaneous treatment with ion exchange resin such as cholestyramine, colestipol<br />hydrochloride, orlistat or laxative such as paraffin oil may reduce the gastrointestinal absorption<br />of vitamin D.<br />The cytotoxic agent actinomycin and imidazole antifungal agents interfere with vitamin D<br />activity by inhibiting the conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D by the<br />kidney enzyme, 25-hydroxyvitamin D-1-hydroxylase.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In pregnancy and lactation the high strength formulation is not recommended and a low strength<br />formulation should be used.<br />Pregnancy<br />There are no or limited amount of data from the use of cholecalciferol in pregnant women.<br />Studies in animals have shown reproductive toxicity (see section 5.3 Preclinical safety data). The<br />recommended daily intake for pregnant women is 400 IU, however, in women who are<br />considered to be vitamin D deficient a higher dose may be required (up to 2000 IU/day).<br />During pregnancy women should follow the advice of their medical practitioner as their<br />requirements may vary depending on the severity of their disease and their response to treatment<br />vitamin D and its metabolites are excreted in breast milk.<br />Breast-feeding<br />Vitamin D can be prescribed while the patient is breast-feeding if necessary. This<br />supplementation does not replace the administration of vitamin D in the neonate.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) Summary of safety profile<br />The most reported adverse reactions are uncommon or rare. The most uncommonly reported adverse<br />reactions are hypercalcaemia and hypercalciuria. (&gt; 0.1 %).<br />b) Adverse reactions are listed below, by system organ class and frequency. Frequencies are<br />defined as: uncommon (&ge;1/1,000, &lt;1/100) or rare (&ge;1/10,000, &lt;1/1,000)<br /><img src="data:image/png;base64,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" alt="" width="483" height="110" vspace="0" hspace="0" border="0" style="width:483px;height:110px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>c) Description of selected adverse reaction<br />Depending on the dose and duration of treatment, severe and prolonged hypercalcaemia with its acute<br />(cardiac arrhythmias, nausea, vomiting, psychic symptoms, disturbances of consciousness) and chronic<br />(increased urgency to urinate, increased thirst, loss of appetite, weight loss, kidney stones, kidney<br />calcification, calcification in tissues outside the skeleton) consequences can occur.<br />d) Pediatric population<br />Frequency, type and severity of adverse reactions in children are similar to those seen in adults.<br />e) Other special population(s)<br />Not applicable<br /><img src="data:image/png;base64,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" alt="" width="530" height="226" vspace="0" hspace="0" border="0" style="width:530px;height:226px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms of overdose<br />Ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) have a relatively low therapeutic<br />index. The threshold for vitamin D intoxication is between 40,000 and 100,000 IU daily for 1 to<br />2 months in adults with normal parathyroid function. Infants and small children may react<br />sensitively to far lower concentrations. Therefore, it is warned against intake of vitamin D<br />without medical supervision.<br />Overdose leads to increased serum and urinary phosphorus levels, as well as hypercalcaemic<br />syndrome and consequently calcium deposits in the tissues and above all in the kidneys<br />(nephrolithiasis, nephrocalcinosis) and the vessels.<br />Discontinue D-CURA when calcaemia exceeds 10.6 mg/dl (2.65 mmol/l) or if the calciuria<br />exceeds 300 mg/24 hours in adults or 4-6 mg/kg/day in children.<br />Chronic overdosage may lead to vascular and organ calcification, as a result of hypercalcaemia.<br />The symptoms of intoxication are little characteristic and manifest as nausea, vomiting, initially<br />also diarrhoea, later constipation, loss of appetite, weariness, headache, muscle pain, joint pain,<br />muscle weakness, persistent sleepiness, azotaemia, polydipsia and polyuria and, in the final<br />stage, dehydration. Typical biochemical findings include hypercalcaemia, hypercalciuria, as well<br />as increased serum 25 hydroxycholecalciferol concentrations.<br />Treatment of overdose<br />Symptoms of chronic vitamin D overdosage may require forced diuresis as well as<br />administration of glucocorticoids or calcitonin.<br />Overdosage requires measures for treating the - often persisting and under certain circumstances<br />life-threatening - hypercalcaemia.<br />The first measure is to discontinue the vitamin D preparation; it takes several weeks to normalise<br />hypercalcaemia caused by vitamin D intoxication.<br />Depending on the degree of hypercalcaemia, measures include a diet that is low in calcium or<br />free of calcium, abundant liquid intake, increase of urinary excretion by means of the drug<br />furosemide, as well as the administration of glucocorticoids and calcitonin.<br />If kidney function is adequate, calcium levels can be reliably lowered by infusions of isotonic<br />sodium chloride solution (3-6 liters in 24 hours) with addition of furosemide and, in some<br />circumstances, also 15 mg/kg body weight/hour sodium edetate accompanied by continuous<br />calcium and ECG monitoring. In oligoanuria, in contrast, haemodialysis (calcium-free dialysate)<br />is necessary.<br />No special antidote exists.<br />It is recommended to point out the symptoms of potential overdose to patients under chronic<br />therapy with higher doses of vitamin D (nausea, vomiting, initially also diarrhoea, later<br />constipation, anorexia, weariness, headache, muscle pain, joint pain, muscle weakness, persistent<br />sleepiness, azotaemia, polydipsia and polyuria).<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Vitamin D, cholecalciferol<br />ATC Code: A11CC05<br />In its biologically active form Vitamin D stimulates intestinal calcium absorption , incorporation<br />of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it<br />promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also<br />stimulated. In the kidney, it inhibits the excretion of calcium and phosphate by promoting tubular<br />resorption. The production of parathyroid hormone (PTH) in the parathyroids is inhibited<br />directly by the biologically active form of vitamin D3. PTH secretion is inhibited additionally by<br />the increased calcium uptake in the small intestine under the influence of biologically active<br />vitamin D.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of vitamin D is well known.<br />Absorption<br />Vitamin D is well absorbed from the gastro-intestinal tract in the presence of bile, so the<br />administration with the major meal of the day might therefore facilitate the absorption of<br />Vitamin D.<br />Distribution and biotransformation<br />It is hydroxylated in the liver to form 25-hydroxy-cholecalciferol and then undergoes further<br />hydroxylation in the kidney to form the active metabolite 1, 25-dihydroxycholecalciferol<br />(calcitriol).<br />Elimination<br />The metabolites circulate in the blood bound to a specific &alpha; - globin, vitamin D and its<br />metabolites are excreted mainly in the bile and faeces.<br />Characteristics in Specific Groups of Subjects or Patients<br />A 57% lower metabolic clearance rate is reported in subjects with renal impairment as compared<br />with that of healthy volunteers.<br />Decreased absorption and increased elimination of vitamin D occurs in subjects with<br />malabsorption.<br />Obese subjects are less able to maintain vitamin D levels with sun exposure, and are likely to<br />require larger oral doses of vitamin D to replace deficits.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pre-clinical studies conducted in various animal species have demonstrated that toxic effects<br />occur in animals at doses much higher than those required for therapeutic use in humans.<br />In toxicity studies at repeated doses, the effects most commonly reported were increased<br />calciuria and decreased phosphaturia and proteinuria.<br />Hypercalcaemia has been reported in high doses. In a state of prolonged hypercalcaemia,<br />histological alterations (calcification) were more frequently borne by the kidneys, heart, aorta,<br />testes, thymus and intestinal mucosa.<br />Colecalciferol has been shown to be teratogenic at high doses in animals.<br />At doses equivalent to those used therapeutically, cholecalciferol has no teratogenic activity.<br />Cholecalciferol has no potential mutagenic or carcinogenic activity.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tocopherol acetate,<br />Polyglyceryl oleate (E475),<br />Olive oil,refined,<br />Sweet orange peel oil.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.<br />Store in the original package, in order to protect from light.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Transparent PVC/PVDC/PE ampoules.<br />Original Pack with 4 ampoules.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements<br />Any unused product or waste material should be disposed of in accordance with local<br />requirements.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAJA Pharmaceuticals
Saudi Arabian Japanese Pharmaceuticals Co. Ltd.
Jeddah Industrial City, Phase IV
Under License from SMB /Belgium
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Feb 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>